Organic anion transporting polypeptide 1A2 mediates fentanyl uptake in cultured cells

Huo,Xing‑Chen; Yang,Hui‑Wen; Huang,Li‑Hua; Zhang,Fan; Pan,Zi‑Ye; Liao,Qin

doi:10.3892/mmr.2019.10796

Organic anion transporting polypeptide 1A2 mediates fentanyl uptake in cultured cells

Authors:
- Xing‑Chen Huo
- Hui‑Wen Yang
- Li‑Hua Huang
- Fan Zhang
- Zi‑Ye Pan
- Qin Liao
View Affiliations

Affiliations: Department of Anesthesiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China, Center for Medical Experiments, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China
Published online on: November 5, 2019 https://doi.org/10.3892/mmr.2019.10796
Pages: 485-492

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Individual differences in the response to fentanyl, which may be caused by different concentrations of the drug in the central nervous system, can complicate analgesic treatment. It has been reported that the organic anion transporting polypeptide (OATP) at the blood‑brain barrier (BBB) in Sprague‑Dawley rats may serve an important role in the transport of fentanyl across the BBB. However, whether human OATP can transport fentanyl has thus far not been reported. The present study aimed to establish a 293 cell line stably overexpressing OATP1A2, and to determine whether OATP1A2 is able to transport fentanyl across the plasma membrane. Initially, 293 cells were transfected with an OATP1A2‑expressing plasmid (referred to as 293‑OATP1A2 cells), and single colonies were selected and characterized following geneticin treatment. Subsequently, reverse transcription‑quantitative polymerase chain reaction and western blot analyses were conducted to verify the transfection efficiency. Furthermore, treatment of 293‑OATP1A2 cells with different concentrations of fexofenadine (FEX) and fentanyl was performed to investigate the transport function of OATP1A2 in 293 cells. FEX and fentanyl uptake experiments were also performed with naringenin, an inhibitor of OATP1A2. The results indicated that FEX and fentanyl uptake was significantly increased in 293‑OATP1A2 cells compared with that in the control‑transfected cells. The 293‑OATP1A2‑mediated uptake of FEX at concentration of 100 nM FEX was ~10‑fold higher than that of 293‑VC cells. The 293‑OATP1A2‑mediated uptake of fentanyl (100 nM) was 5.1‑fold higher compared with that in 293‑VC cells. In 293‑OATP1A2 cells, the uptake of FEX without OATP1A2 inhibitor naringenin (100 µg/ml) was 2.8‑fold higher compared with that in the presence of naringenin, and the uptake of fentanyl without naringenin was 7.3‑fold higher compared with that in the presence of naringenin (100 µg/ml). In conclusion, 293 cells that overexpressed OATP1A2 were successfully constructed, and OATP1A2 was revealed to mediate fentanyl uptake in the cultured cells.

View Figures

View References

1	Lane ME: The transdermal delivery of fentanyl. Eur J Pharm Biopharm. 84:449–455. 2013. View Article : Google Scholar : PubMed/NCBI
2	Upton RN: Cerebral uptake of drugs in humans. Clin Exp Pharmacol Physiol. 34:695–701. 2007. View Article : Google Scholar : PubMed/NCBI
3	Henthorn TK, Liu Y, Mahapatro M and Ng KY: Active transport of fentanyl by the blood-brain barrier. J Pharmacol Exp Ther. 289:1084–1089. 1999.PubMed/NCBI
4	Elkiweri IA, Zhang YL, Christians U, Ng KY, Tissot van Patot MC and Henthorn TK: Competitive substrates for P-glycoprotein and organic anion protein transporters differentially reduce blood organ transport of fentanyl and loperamide: Pharmacokinetics and pharmacodynamics in Sprague-Dawley rats. Anesth Analg. 108:149–159. 2009. View Article : Google Scholar : PubMed/NCBI
5	Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A and Meier PJ: Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther. 294:73–79. 2000.PubMed/NCBI
6	Roth M, Obaidat A and Hagenbuch B: OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol. 165:1260–1287. 2012. View Article : Google Scholar : PubMed/NCBI
7	Lee W, Glaeser H, Smith LH, Roberts RL, Moeckel GW, Gervasini G, Leake BF and Kim RB: Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): Implications for altered drug disposition and central nervous system drug entry. J Biol Chem. 280:9610–9617. 2005. View Article : Google Scholar : PubMed/NCBI
8	Obaidat A, Roth M and Hagenbuch B: The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu Rev Pharmacol Toxicol. 52:135–151. 2012. View Article : Google Scholar : PubMed/NCBI
9	Bronger H, König J, Kopplow K, Steiner HH, Ahmadi R, Herold-Mende C, Keppler D and Nies AT: ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res. 65:11419–11428. 2005. View Article : Google Scholar : PubMed/NCBI
10	Zhou Y, Yuan J, Li Z, Wang Z, Cheng D, Du Y, Li W, Kan Q and Zhang W: Genetic polymorphisms and function of the organic anion-transporting polypeptide 1A2 and its clinical relevance in drug disposition. Pharmacology. 95:201–208. 2015. View Article : Google Scholar : PubMed/NCBI
11	Gong IY and Kim RB: Impact of genetic variation in OATP transporters to drug disposition and response. Drug Metab Pharmacokinet. 28:4–18. 2013. View Article : Google Scholar : PubMed/NCBI
12	König J, Glaeser H, Keiser M, Mandery K, Klotz U and Fromm MF: Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake. Drug Metab Dispos. 39:1097–1102. 2011. View Article : Google Scholar : PubMed/NCBI
13	Forster S, Thumser AE, Hood SR and Plant N: Characterization of rhodamine-123 as a tracer dye for use in in vitro drug transport assays. PLoS One. 7:e332532012. View Article : Google Scholar : PubMed/NCBI
14	Iusuf D, Hendrikx JJ, van Esch A, van de Steeg E, Wagenaar E, Rosing H, Beijnen JH and Schinkel AH: Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel. Int J Cancer. 136:225–233. 2015. View Article : Google Scholar : PubMed/NCBI
15	Durmus S, Naik J, Buil L, Wagenaar E, van Tellingen O and Schinkel AH: In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters. Int J Cancer. 135:1700–1710. 2014. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Cvetkovic M, Leake B, Fromm MF, Wilkinson GR and Kim RB: OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos. 27:866–871. 1999.PubMed/NCBI
18	Shimizu M, Fuse K, Okudaira K, Nishigaki R, Maeda K, Kusuhara H and Sugiyama Y: Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans. Drug Metab Dispos. 33:1477–1481. 2005. View Article : Google Scholar : PubMed/NCBI
19	Glaeser H, Bujok K, Schmidt I, Fromm MF and Mandery K: Organic anion transporting polypeptides and organic cation transporter 1 contribute to the cellular uptake of the flavonoid quercetin. Naunyn Schmiedebergs Arch Pharmacol. 387:883–891. 2014. View Article : Google Scholar : PubMed/NCBI
20	Verplaetse R and Tytgat J: Development and validation of a sensitive ultra performance liquid chromatography tandem mass spectrometry method for the analysis of fentanyl and its major metabolite norfentanyl in urine and whole blood in forensic context. J Chromatogr B Analyt Technol Biomed Life Sci. 878:1987–1996. 2010. View Article : Google Scholar : PubMed/NCBI
21	Mandery K, Bujok K, Schmidt I, Keiser M, Siegmund W, Balk B, Konig J, Fromm MF and Glaeser H: Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochem Pharmacol. 80:1746–1753. 2010. View Article : Google Scholar : PubMed/NCBI
22	Taub ME, Mease K, Sane RS, Watson CA, Chen L, Ellens H, Hirakawa B, Reyner EL, Jani M and Lee CA: Digoxin is not a substrate for organic anion-transporting polypeptide transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but is a substrate for a sodium-dependent transporter expressed in HEK293 cells. Drug Metab Dispos. 39:2093–2102. 2011. View Article : Google Scholar : PubMed/NCBI
23	Ziesenitz VC, König SK, Mahlke N, Jantos R, Skopp G, Weiss J, Haefeli WE and Mikus G: Fentanyl pharmacokinetics is not dependent on hepatic uptake by organic anion-transporting polypeptide 1B1 in human beings. Basic Clin Pharmacol Toxicol. 113:43–48. 2013. View Article : Google Scholar : PubMed/NCBI
24	Ose A, Kusuhara H, Endo C, Tohyama K, Miyajima M, Kitamura S and Sugiyama Y: Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier. Drug Metab Dispos. 38:168–176. 2010. View Article : Google Scholar : PubMed/NCBI
25	Ronaldson PT, Finch JD, Demarco KM, Quigley CE and Davis TP: Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier. J Pharmacol Exp Ther. 336:827–839. 2011. View Article : Google Scholar : PubMed/NCBI
26	Lin YC, Boone M, Meuris L, Lemmens I, Van Roy N, Soete A, Reumers J, Moisse M, Plaisance S, Drmanac R, et al: Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations. Nat Commun. 5:47672014. View Article : Google Scholar : PubMed/NCBI
27	Thomas P and Smart TG: HEK293 cell line: A vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods. 51:187–200. 2005. View Article : Google Scholar : PubMed/NCBI
28	Stepanenko AA and Dmitrenko VV: HEK293 in cell biology and cancer research: Phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution. Gene. 569:182–190. 2015. View Article : Google Scholar : PubMed/NCBI